LJI selected as member of ARPA-H Investor Catalyst Hub Spoke Network
LJI joins a nationwide network working to accelerate transformative health solutions
LJI joins a nationwide network working to accelerate transformative health solutions
LJI scientists zero in on T cells that may drive autoimmune disease in human patients
Leading immunologist honored for research into the roots of autoimmunity, cancer development, and more
LJI scientists share a new, rapid method for studying phosphorylation and other post-translational modifications
LJI's Flow Cytometry Core brings cutting-edge technology to immune system researchers
The new Reina Lab aims to charge up killer T cells against tumors
International team zeros in on immune cells responsible for some hard-to-treat asthma cases
LA JOLLA, CA—Asthma is more dangerous than many people realize. An estimated 10 Americans die everyday from asthma, and the
LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema
Some neurological diseases show up more in men versus women. Researchers need to know why.
“The whole mucosal immune system is so fascinating. It has to operate in an environment of extremes.”
LJI postdoctoral research Jermaine Khumalo, Ph.D., has a new strategy for studying asthma.